Symposium Speaker Spotlight: Dr. Zev Wainberg to discuss Advances in Chemotherapy

The Hirshberg Foundation is excited to have Dr. Wainberg join us at the 13th Annual Symposium on Pancreatic Cancer to share information about the advancements that have been made in the treatment of this disease.

Dr. Zev Wainberg is Associate Professor of Medicine at UCLA and co-director of the UCLA GI Oncology Program. He was trained in medical oncology and hematology at UCLA. He completed his residency training at Albert Einstein College of Medicine and received his MD from the Sackler School of Medicine, New York Program at Tel Aviv University. His research involves a variety of clinical trials in multiple gastrointestinal cancers including pancreas, colon, gastric and esophageal.

Dr. Wainberg’s laboratory-based research efforts involve the testing of novel therapeutics against all gastrointestinal cancers. Currently, he is the recipient of several grants focused on the targeting of cancer stem cells and in molecular classification of GI cancers. Dr. Wainberg will speak on recent Advances in Chemotherapy at the 13th Annual Symposium at UCLA.